Skip to main content

Lee Chan Henry's Form 4 filing

BeOne Medicines Ltd. (ONC) · filed Dec 12, 2025

Accession no.
0001980648-25-000006
Filed
Dec 12, 2025
Trade date
Dec 10-11, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 6 derivative transactions. Open-market sales total $213.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lee Chan HenryCIK 0001980648Officer (SVP, General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 10, 2025American Depositary SharesMOption exerciseAcquired+101$194.47+$19,641.47101Direct
Dec 10, 2025American Depositary SharesMOption exerciseAcquired+133$213.32+$28,371.56234Direct
Dec 10, 2025American Depositary SharesMOption exerciseAcquired+98$159.03+$15,584.94332Direct
Dec 10, 2025American Depositary SharesSSaleDisposed−332$318.28−$105,668.960Direct
Dec 11, 2025American Depositary SharesMOption exerciseAcquired+101$194.47+$19,641.47101Direct
Dec 11, 2025American Depositary SharesMOption exerciseAcquired+133$213.32+$28,371.56234Direct
Dec 11, 2025American Depositary SharesMOption exerciseAcquired+98$159.03+$15,584.94332Direct
Dec 11, 2025American Depositary SharesSSaleDisposed−332$325.00−$107,9000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 10, 2025Ordinary SharesMOption exerciseDisposed−1,313$0.00$034,385Direct
Dec 10, 2025Ordinary SharesMOption exerciseDisposed−1,729$0.00$0102,206Direct
Dec 10, 2025Ordinary SharesMOption exerciseDisposed−1,274$0.00$0121,940Direct
Dec 11, 2025Ordinary SharesMOption exerciseDisposed−1,313$0.00$033,072Direct
Dec 11, 2025Ordinary SharesMOption exerciseDisposed−1,729$0.00$0100,477Direct
Dec 11, 2025Ordinary SharesMOption exerciseDisposed−1,274$0.00$0120,666Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)